ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Robert G. Johnson
Jatinder S. Dhillon
Robert L. Thurer
Ronald M. Weintraub
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, R. G.
Right arrow Articles by Weintraub, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, R. G.
Right arrow Articles by Weintraub, R. M.

Ann Thorac Surg 1990;49:740-745
© 1990 The Society of Thoracic Surgeons

Articles

Aortic valve operation after percutaneous aortic balloon valvuloplasty

Robert G. Johnson, MD*, Jatinder S. Dhillon, MD, Robert L. Thurer, MD, Robert D. Safian, MD, Ronald M. Weintraub, MD

Sections of Cardiothoracic Surgery and Cardiology, Beth Israel Hospital, Harvard Medical School, and the Charles A. Dana Research Center, Boston, Massachusetts, USA

* Address reprint requests to Dr Johnson, 330 Brookline Ave, Dana 905, Boston, MA 02215.

From January 1986 to May 1988, 179 patients underwent percutaneous aortic balloon valvuloplasty at our institution. Forty-five (25%) patients subsequently required operation at this institution or other institutions. The indication for percutaneous aortic balloon valvuloplasty was patient preference in 15 and an estimation of excessive operative mortality in 30. Three patients required emergency operation immediately after valvuloplasty, and the other 42 had an elective operation a mean of 7.8 months afterward. All but 3 of these patients had major progression of symptoms, and all had valvular restenosis. In spite of the high-risk status of these patients, there were only four hospital deaths among the 45 patients. Three additional patients have died a mean of 11.4 months postoperatively. The condition of all survivors remains clinically improved after the valve operations. Percutaneous aortic balloon valvuloplasty must be recognized as a palliative procedure, and should be reserved for patients who are truly not candidates for operation or situations in which a brief period of reduction in gradient might improve a patient's condition before operation.




This article has been cited by other articles:


Home page
 J Am Coll Cardiol IntvHome page
I. Ben-Dor, A. D. Pichard, L. F. Satler, S. A. Goldstein, A. I. Syed, M. A. Gaglia Jr, G. Weissman, G. Maluenda, M. A. Gonzalez, K. Wakabayashi, et al.
Complications and Outcome of Balloon Aortic Valvuloplasty in High-Risk or Inoperable Patients
J. Am. Coll. Cardiol. Intv., November 1, 2010; 3(11): 1150 - 1156.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1990 by The Society of Thoracic Surgeons.